Speakers by industry: a global gathering of key opinion leaders
Pharmaceutical
1. Professor Ian Cotgreave, Director of Molecular Toxicology, Safety Assessment, AstraZeneca
2. Dr John McNeish, Senior Director, Pfizer Global R&D
3. Dr Aaron Chuang, Drug Discovery Stem Cell Coordinator and Manager of
Cellular Neurobiology, Neurodegeneration Research Department, GlaxoSmithKline
4. Dr Ajan Reginald, Global Head of Emerging Group Research, Roche
5. Roger Guidi, Vice President, Venture Capital, Johnson and Johnson Development Corporation
Biotech
1. Hugh Ilyine, Chief Operating Officer, Stem Cell Sciences
2. Dr Michael Hunt, Chief Executive Officer, ReNeuron
3. Dr Tim Allsopp, Chief Scientific Officer, Stem Cell Sciences
4. Dr Yen Choo, Founder and Chief Executive Officer, Plasticell
5. Dr Michael West, Chief Executive Officer, BioTime
6. Dr Elyse Seltzer, Chief Medical Officer, Tengion
7. Dr Michael Siani-Rose, President and Founder, Theregen
8. Dr Paul Kemp, Chief Executive Officer, Intercytex
9. Dr Randal Mills, Chief Executive Officer, Osiris Therapeutics
10. Dr Nicolas L'Heureux, Chief Scientific Officer, Cytograft
11. Dr Thomas Okarma, Chief Executive Officer, Geron
12. Dr Alan Lewis, Chief Executive Officer, Novocell
13. Dr Gail Naughton, Chief Executive Officer, Histogen
14. Dr Geoff Mackay, Chief Executive Officer, Organogenesis
15. Dr Ralph Snodgrass, President and Chief Executive Officer, Vistagen Therapeutics
16. Dr Mats Lundvall, Chief Executive Officer, Cellartis
17. Dr Petter Björquist, Senior Principal Scientist, Head Hepatocyte/Beta-Cell Development, Cellartis
18. Dr Alfred Sapse, President, Stem Cell Pharma Inc
Government and NGO
1. Dr Alan Trounson, President, California Institute of Regenerative Medicine
2. Bernard Siegel, Executive Director, Genetics Policy Institute
3. Dr Alan Russell, Director, McGowan Institute for Regenerative Medicine
4. Dr Steven Bauer, Chief of the Laboratory of Stem Cell Biology, Division of Cellular and Gene Therapies, Centre for Biologics Evaluation
and Research, FDA
5. Dr Philip Wright, Chairman, SC4SM, Director of Science and Technology, ABPI
6. Mark Bale, Deputy Director of Scientific Development & Bioethics, Department of Health, UK
7. Sir Richard Sykes, Chairman, UK Stem Cell Foundation
Academic and Research Institutes
1. Dr Chris Mason, Director, Regenerative Medicine Bioprocessing Unit, University College London
2. Dr Stephen Minger, Director, Stem Cell Biology Laboratory, Wolfson Centre for Age-Related Diseases, King’s College London
3. Dr Gabriela Gebrin Cezar, Assistant Professor, Department of Animal Sciences, University of Wisconsin-Madison
4. Professor Oliver Brüstle, Director, Institute of Reconstructive Neurobiology, University of Bonn and Scientific Director, LIFE & BRAIN
Contract Services
1. David Smith, Head of Cell Therapy, Lonza
2. Dr Stewart Craig, Chief Technical Officer and Vice President, Progenitor Cell Therapy
Legal Firms
1. James Lawford Davies, Solicitor, Clifford-Chance and University of Newcastle
2. Gareth Williams, Solicitor, Marks and Clerk
3. Dr Ivor Elrifi, Co-Chair Intellectual Property Section, Mintz Levin
Venture Capital
1. Gregory Bonfiglio, Managing Director, Partner, Proteus Venture Partners
Consultants
1. Richard Archer, Managing Director, Two BC Ltd
